+1-888-308-5802     
News Contact Us

Sydney share-trading firm Superhero secures over $8 million in capital

Author : Saipriya Iyer | Published Date : 2020-09-07 

Superhero, an emerging Sydney-based share trading startup, has reportedly made its entry into the market with over $8 million in capital secured from some of Australia’s largest tech firms.

The $8 million investment round was led by the chief and founder of BNPL fintech firm, Zip, Larry Diamond, and Garen Azoyan, an early Zip investor. The round also saw participation from Leon Zweir, senior partner at Arnold Block Leibler. Additionally, Zip chairman, Philip Crutchfield also invested in the firm and would be joining Superhero as a non-executive chair.

The new startup is headed by John Winters, a renowned wealth management veteran, and Wayne Baskin, chief technology officer, Booktopia. Wayne Baskin was previously a member of renowned Australian BNPL (buy-now-pay-later) enterprise, Afterpay.

Nick Molnar, Afterpay chief and founder has also previously backed the Superhero business by participating in an earlier seed funding round.

Superhero intends to bring change to the country’s online investment market by making the overall experience much more accessible and transparent, and offering a flat fee of $5. Though there a number of different platforms that offer investors access to stocks that are US-listed, Superhero has been specifically designed to provide Australian investors access to businesses that are Aussie-listed.

John Winters, the co-founder and chief of Superhero, stated that Australian has not been the point of focus for many industry players, wherein nobody has really reinvented the user experience of value proposition or for Australia, and for shares listed on the ASX.

Winters further stated that the company sees this as a prominent opportunity for Australian investors than going offshore immediately.

While the company officially takes off today, Superhero co-founders have diligently been developing the product over the past 2.5 years.

The pandemic has driven more people towards adopting fintech tools, as well as share-trading platforms like the US-based Robin Hood, making this an ideal time for Superhero to enter the market.

Source credit: https://www.smartcompany.com.au/startupsmart/news/superhero-8-million-raise-afterpay-zip/

About Author

Saipriya Iyer

Saipriya Iyer

Saipriya Iyer presently works as a content developer for fractovia.org. Having dabbled with the domain of content creation for nearly half a decade, she now boasts of an enviable portfolio, holding substantial experience in penning down pieces related to technology, finance, and a wide spectrum of other industry verticals. A qualified computer engineering graduate from the University of Pune, Saipriya can often be found leveraging her knowledge of software technology and electronics in her write-ups. She can be contacted at- [email protected] | https://twitter.com/saipriya_i

Related News

Adobe plans new hiring spree as the company hits record revenues

Published Date: 2020-09-17         Author: Saipriya Iyer

As the COVID-19 pandemic continues to impact the global business landscape, software companies and tech firms seem to be faring much better than other enterprises owing to their compatibility with the work-from-home trend, which ensures employee safety and smooth working of the organization. With ot... Read More

UK housing industry at its four year high according to estate agents

Published Date: 2020-09-11         Author: Saipriya Iyer

Stamp duty cuts and an upsurge in the demand for homes having gardens during the pandemic, has reportedly fueled the housing industry to its highest in the past four years, as per the estate agents and surveyors. Over 44% members of RICS’ (Royal Institute of Chartered Surveyors) have regist... Read More

Hanmi Pharma’s Oraxol receives priority review designation from US FDA

Published Date: 2020-09-03         Author: Saipriya Iyer

Hanmi Pharmaceuticals, a renowned South Korean pharmaceutical firm, has reportedly announced that its new oral anticancer drug, Oraxol, has been assigned the priority review designation by the United States Food and Drug Administration (US FDA). Speaking on the same, Athenex, partner of Hanmi sta... Read More

© 2020 Fractovia. All Rights Reserved